The S&P 500 futures currently trade 41 points above fair value.
Drugmakers such as Eli Lilly (LLY 1,061.02, +40.18, +3.9%) and Novo Nordisk (NVO 46.42, +3.09, +7.1%) are higher in the premarket after the FDA announced it "will take swift action against companies mass-marketing illegal copycat drugs," according to CNBC.
Additionally, President Trump announced the launch of TrumpRx, which offers discounted pricing on select drugs.